nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—urinary bladder cancer	0.326	1	CrCtD
Leucovorin—TYMS—urinary bladder cancer	0.18	1	CbGaD
Leucovorin—Raltitrexed—Methotrexate—urinary bladder cancer	0.0431	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—urinary bladder cancer	0.0431	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—urinary bladder cancer	0.0431	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—urinary bladder cancer	0.0431	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—urinary bladder cancer	0.0431	0.2	CrCrCtD
Leucovorin—TYMS—Gemcitabine—urinary bladder cancer	0.0414	0.188	CbGbCtD
Leucovorin—TYMS—Fluorouracil—urinary bladder cancer	0.0354	0.161	CbGbCtD
Leucovorin—TYMS—Methotrexate—urinary bladder cancer	0.0195	0.0889	CbGbCtD
Leucovorin—ABCC3—Fluorouracil—urinary bladder cancer	0.0183	0.0836	CbGbCtD
Leucovorin—ABCC3—Cisplatin—urinary bladder cancer	0.0156	0.071	CbGbCtD
Leucovorin—ABCC3—Etoposide—urinary bladder cancer	0.0153	0.0698	CbGbCtD
Leucovorin—ABCC4—Fluorouracil—urinary bladder cancer	0.014	0.0639	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—urinary bladder cancer	0.0104	0.0476	CbGbCtD
Leucovorin—ABCC3—Methotrexate—urinary bladder cancer	0.0101	0.0461	CbGbCtD
Leucovorin—ABCC2—Carboplatin—urinary bladder cancer	0.00829	0.0378	CbGbCtD
Leucovorin—ABCC4—Methotrexate—urinary bladder cancer	0.00773	0.0352	CbGbCtD
Leucovorin—ABCC2—Cisplatin—urinary bladder cancer	0.00708	0.0323	CbGbCtD
Leucovorin—ABCC2—Etoposide—urinary bladder cancer	0.00696	0.0317	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—urinary bladder cancer	0.00474	0.0216	CbGbCtD
Leucovorin—ABCC2—Methotrexate—urinary bladder cancer	0.0046	0.0209	CbGbCtD
Leucovorin—ABCC3—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00179	0.0942	CbGpPWpGaD
Leucovorin—ABCC2—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00142	0.0747	CbGpPWpGaD
Leucovorin—Pralatrexate—SLC19A1—urinary bladder cancer	0.000784	0.348	CrCbGaD
Leucovorin—TYMS—G1/S-Specific Transcription—RRM2—urinary bladder cancer	0.00061	0.0322	CbGpPWpGaD
Leucovorin—TYMS—Pyrimidine metabolism—TYMP—urinary bladder cancer	0.000593	0.0313	CbGpPWpGaD
Leucovorin—TYMS—prostate gland—urinary bladder cancer	0.000549	0.117	CbGeAlD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000505	0.0267	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00046	0.0243	CbGpPWpGaD
Leucovorin—ABCC3—prostate gland—urinary bladder cancer	0.000451	0.0959	CbGeAlD
Leucovorin—TYMS—Podofilox—Etoposide—urinary bladder cancer	0.000449	0.713	CbGdCrCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000401	0.0211	CbGpPWpGaD
Leucovorin—TYMS—smooth muscle tissue—urinary bladder cancer	0.000389	0.0828	CbGeAlD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000381	0.0201	CbGpPWpGaD
Leucovorin—ABCC4—prostate gland—urinary bladder cancer	0.000372	0.0792	CbGeAlD
Leucovorin—ABCC2—prostate gland—urinary bladder cancer	0.00036	0.0767	CbGeAlD
Leucovorin—TYMS—G1/S-Specific Transcription—CCNE1—urinary bladder cancer	0.00036	0.019	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000359	0.0189	CbGpPWpGaD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—RRM2—urinary bladder cancer	0.000359	0.0189	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000358	0.0189	CbGpPWpGaD
Leucovorin—Methotrexate—SLC19A1—urinary bladder cancer	0.000346	0.153	CrCbGaD
Leucovorin—ABCC3—renal system—urinary bladder cancer	0.000307	0.0654	CbGeAlD
Leucovorin—Raltitrexed—TYMS—urinary bladder cancer	0.000301	0.133	CrCbGaD
Leucovorin—TYMS—female reproductive system—urinary bladder cancer	0.0003	0.0639	CbGeAlD
Leucovorin—ABCC3—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000297	0.0157	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000279	0.0147	CbGpPWpGaD
Leucovorin—TYMS—vagina—urinary bladder cancer	0.000271	0.0578	CbGeAlD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000259	0.0137	CbGpPWpGaD
Leucovorin—ABCC4—renal system—urinary bladder cancer	0.000253	0.054	CbGeAlD
Leucovorin—ABCC3—female reproductive system—urinary bladder cancer	0.000246	0.0524	CbGeAlD
Leucovorin—ABCC2—renal system—urinary bladder cancer	0.000245	0.0523	CbGeAlD
Leucovorin—TYMS—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000231	0.0122	CbGpPWpGaD
Leucovorin—Pralatrexate—TYMS—urinary bladder cancer	0.000228	0.101	CrCbGaD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—CCNE1—urinary bladder cancer	0.000212	0.0112	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—XRCC1—urinary bladder cancer	0.000211	0.0111	CbGpPWpGaD
Leucovorin—TYMS—One Carbon Metabolism—MTHFR—urinary bladder cancer	0.000207	0.0109	CbGpPWpGaD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000205	0.0108	CbGpPWpGaD
Leucovorin—ABCC4—female reproductive system—urinary bladder cancer	0.000203	0.0432	CbGeAlD
Leucovorin—ABCC2—female reproductive system—urinary bladder cancer	0.000197	0.0418	CbGeAlD
Leucovorin—TYMS—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000193	0.0102	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—RRM2—urinary bladder cancer	0.00019	0.01	CbGpPWpGaD
Leucovorin—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—urinary bladder cancer	0.000186	0.00982	CbGpPWpGaD
Leucovorin—Pemetrexed—TYMS—urinary bladder cancer	0.000182	0.0808	CrCbGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000182	0.00958	CbGpPWpGaD
Leucovorin—TYMS—Azacitidine—Gemcitabine—urinary bladder cancer	0.000181	0.287	CbGdCrCtD
Leucovorin—TYMS—Nucleotide metabolism—RRM2—urinary bladder cancer	0.00018	0.00952	CbGpPWpGaD
Leucovorin—TYMS—lymph node—urinary bladder cancer	0.000175	0.0374	CbGeAlD
Leucovorin—ABCC3—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000175	0.00923	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000172	0.00908	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000165	0.00872	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000164	0.00868	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000162	0.00853	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.00016	0.00843	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000152	0.00802	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.00015	0.00793	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.00015	0.00793	CbGpPWpGaD
Leucovorin—ABCC3—lymph node—urinary bladder cancer	0.000144	0.0306	CbGeAlD
Leucovorin—ABCC4—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000141	0.00745	CbGpPWpGaD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—RB1—urinary bladder cancer	0.000141	0.00743	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000141	0.00742	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000139	0.00732	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—RRM2—urinary bladder cancer	0.000138	0.00728	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—SMC1B—urinary bladder cancer	0.000119	0.0063	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000119	0.00628	CbGpPWpGaD
Leucovorin—ABCC4—lymph node—urinary bladder cancer	0.000119	0.0253	CbGeAlD
Leucovorin—Tetrahydrofolic acid—MTHFR—urinary bladder cancer	0.000117	0.0518	CrCbGaD
Leucovorin—Folic Acid—MTHFR—urinary bladder cancer	0.000117	0.0518	CrCbGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RRM2—urinary bladder cancer	0.000116	0.00614	CbGpPWpGaD
Leucovorin—ABCC2—lymph node—urinary bladder cancer	0.000115	0.0245	CbGeAlD
Leucovorin—TYMS—E2F transcription factor network—CCNE1—urinary bladder cancer	0.000112	0.00592	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000107	0.00565	CbGpPWpGaD
Leucovorin—Methotrexate—TYMS—urinary bladder cancer	0.0001	0.0445	CrCbGaD
Leucovorin—TYMS—Nucleotide metabolism—GPX1—urinary bladder cancer	9.89e-05	0.00522	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	9.74e-05	0.00514	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	9.43e-05	0.00498	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—PLAU—urinary bladder cancer	9.09e-05	0.00479	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—ATM—urinary bladder cancer	8.62e-05	0.00455	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	8.16e-05	0.00431	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—CCNE1—urinary bladder cancer	8.14e-05	0.00429	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	8.11e-05	0.00428	CbGpPWpGaD
Leucovorin—Methotrexate—MTHFR—urinary bladder cancer	7.99e-05	0.0354	CrCbGaD
Leucovorin—Renal failure acute—Methotrexate—urinary bladder cancer	7.85e-05	0.00242	CcSEcCtD
Leucovorin—Malaise—Gemcitabine—urinary bladder cancer	7.69e-05	0.00237	CcSEcCtD
Leucovorin—Leukopenia—Gemcitabine—urinary bladder cancer	7.63e-05	0.00236	CcSEcCtD
Leucovorin—Chills—Etoposide—urinary bladder cancer	7.51e-05	0.00232	CcSEcCtD
Leucovorin—Leukopenia—Fluorouracil—urinary bladder cancer	7.51e-05	0.00232	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CREBBP—urinary bladder cancer	7.49e-05	0.00395	CbGpPWpGaD
Leucovorin—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	7.48e-05	0.00231	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—RB1—urinary bladder cancer	7.47e-05	0.00394	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	7.46e-05	0.00394	CbGpPWpGaD
Leucovorin—Alopecia—Etoposide—urinary bladder cancer	7.39e-05	0.00228	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—urinary bladder cancer	7.39e-05	0.00228	CcSEcCtD
Leucovorin—Ill-defined disorder—Cisplatin—urinary bladder cancer	7.38e-05	0.00228	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—urinary bladder cancer	7.34e-05	0.00227	CcSEcCtD
Leucovorin—Dyspepsia—Thiotepa—urinary bladder cancer	7.28e-05	0.00225	CcSEcCtD
Leucovorin—Convulsion—Fluorouracil—urinary bladder cancer	7.27e-05	0.00224	CcSEcCtD
Leucovorin—Decreased appetite—Thiotepa—urinary bladder cancer	7.19e-05	0.00222	CcSEcCtD
Leucovorin—Discomfort—Gemcitabine—urinary bladder cancer	7.17e-05	0.00221	CcSEcCtD
Leucovorin—Malaise—Cisplatin—urinary bladder cancer	7.17e-05	0.00221	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	7.14e-05	0.00221	CcSEcCtD
Leucovorin—Fatigue—Thiotepa—urinary bladder cancer	7.13e-05	0.0022	CcSEcCtD
Leucovorin—Dysgeusia—Etoposide—urinary bladder cancer	7.13e-05	0.0022	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—urinary bladder cancer	7.12e-05	0.0022	CcSEcCtD
Leucovorin—Leukopenia—Cisplatin—urinary bladder cancer	7.12e-05	0.0022	CcSEcCtD
Leucovorin—Constipation—Thiotepa—urinary bladder cancer	7.08e-05	0.00218	CcSEcCtD
Leucovorin—Discomfort—Fluorouracil—urinary bladder cancer	7.05e-05	0.00218	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	7e-05	0.00216	CcSEcCtD
Leucovorin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	6.96e-05	0.00215	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—urinary bladder cancer	6.92e-05	0.00214	CcSEcCtD
Leucovorin—Infection—Gemcitabine—urinary bladder cancer	6.92e-05	0.00213	CcSEcCtD
Leucovorin—Confusional state—Fluorouracil—urinary bladder cancer	6.9e-05	0.00213	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—urinary bladder cancer	6.89e-05	0.00364	CbGpPWpGaD
Leucovorin—Convulsion—Cisplatin—urinary bladder cancer	6.89e-05	0.00213	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	6.86e-05	0.00362	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	6.84e-05	0.00211	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	6.84e-05	0.00361	CbGpPWpGaD
Leucovorin—Feeling abnormal—Thiotepa—urinary bladder cancer	6.82e-05	0.00211	CcSEcCtD
Leucovorin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	6.82e-05	0.0021	CcSEcCtD
Leucovorin—Infection—Fluorouracil—urinary bladder cancer	6.8e-05	0.0021	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—urinary bladder cancer	6.79e-05	0.0021	CcSEcCtD
Leucovorin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	6.77e-05	0.00209	CcSEcCtD
Leucovorin—Skin disorder—Gemcitabine—urinary bladder cancer	6.76e-05	0.00209	CcSEcCtD
Leucovorin—Ill-defined disorder—Etoposide—urinary bladder cancer	6.76e-05	0.00209	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—NQO1—urinary bladder cancer	6.75e-05	0.00356	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	6.7e-05	0.00207	CcSEcCtD
Leucovorin—Discomfort—Cisplatin—urinary bladder cancer	6.69e-05	0.00206	CcSEcCtD
Leucovorin—Anorexia—Gemcitabine—urinary bladder cancer	6.63e-05	0.00205	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—urinary bladder cancer	6.59e-05	0.00203	CcSEcCtD
Leucovorin—Urticaria—Thiotepa—urinary bladder cancer	6.57e-05	0.00203	CcSEcCtD
Leucovorin—Malaise—Etoposide—urinary bladder cancer	6.57e-05	0.00203	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—urinary bladder cancer	6.56e-05	0.00346	CbGpPWpGaD
Leucovorin—Body temperature increased—Thiotepa—urinary bladder cancer	6.54e-05	0.00202	CcSEcCtD
Leucovorin—Abdominal pain—Thiotepa—urinary bladder cancer	6.54e-05	0.00202	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	6.53e-05	0.00345	CbGpPWpGaD
Leucovorin—Anorexia—Fluorouracil—urinary bladder cancer	6.52e-05	0.00201	CcSEcCtD
Leucovorin—Leukopenia—Etoposide—urinary bladder cancer	6.52e-05	0.00201	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	6.49e-05	0.00342	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Cisplatin—urinary bladder cancer	6.49e-05	0.002	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	6.48e-05	0.002	CcSEcCtD
Leucovorin—Infection—Cisplatin—urinary bladder cancer	6.45e-05	0.00199	CcSEcCtD
Leucovorin—Loss of consciousness—Etoposide—urinary bladder cancer	6.4e-05	0.00198	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—urinary bladder cancer	6.4e-05	0.00198	CcSEcCtD
Leucovorin—Thrombocytopenia—Cisplatin—urinary bladder cancer	6.35e-05	0.00196	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—urinary bladder cancer	6.35e-05	0.00196	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—NQO1—urinary bladder cancer	6.35e-05	0.00335	CbGpPWpGaD
Leucovorin—Convulsion—Etoposide—urinary bladder cancer	6.31e-05	0.00195	CcSEcCtD
Leucovorin—Skin disorder—Cisplatin—urinary bladder cancer	6.3e-05	0.00195	CcSEcCtD
Leucovorin—Dyspnoea—Gemcitabine—urinary bladder cancer	6.21e-05	0.00192	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—urinary bladder cancer	6.19e-05	0.00191	CcSEcCtD
Leucovorin—Anorexia—Cisplatin—urinary bladder cancer	6.18e-05	0.00191	CcSEcCtD
Leucovorin—Discomfort—Etoposide—urinary bladder cancer	6.13e-05	0.00189	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.12e-05	0.00323	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—ESPL1—urinary bladder cancer	6.11e-05	0.00323	CbGpPWpGaD
Leucovorin—Dyspnoea—Fluorouracil—urinary bladder cancer	6.1e-05	0.00188	CcSEcCtD
Leucovorin—Hypersensitivity—Thiotepa—urinary bladder cancer	6.1e-05	0.00188	CcSEcCtD
Leucovorin—Decreased appetite—Gemcitabine—urinary bladder cancer	6.05e-05	0.00187	CcSEcCtD
Leucovorin—Dyspepsia—Fluorouracil—urinary bladder cancer	6.02e-05	0.00186	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6.01e-05	0.00186	CcSEcCtD
Leucovorin—Fatigue—Gemcitabine—urinary bladder cancer	6e-05	0.00185	CcSEcCtD
Leucovorin—Confusional state—Etoposide—urinary bladder cancer	5.99e-05	0.00185	CcSEcCtD
Leucovorin—Constipation—Gemcitabine—urinary bladder cancer	5.95e-05	0.00184	CcSEcCtD
Leucovorin—Decreased appetite—Fluorouracil—urinary bladder cancer	5.95e-05	0.00184	CcSEcCtD
Leucovorin—Anaphylactic shock—Etoposide—urinary bladder cancer	5.94e-05	0.00183	CcSEcCtD
Leucovorin—Asthenia—Thiotepa—urinary bladder cancer	5.94e-05	0.00183	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	5.91e-05	0.00182	CcSEcCtD
Leucovorin—Infection—Etoposide—urinary bladder cancer	5.9e-05	0.00182	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	5.88e-05	0.00181	CcSEcCtD
Leucovorin—Pruritus—Thiotepa—urinary bladder cancer	5.85e-05	0.00181	CcSEcCtD
Leucovorin—Thrombocytopenia—Etoposide—urinary bladder cancer	5.82e-05	0.0018	CcSEcCtD
Leucovorin—Dyspnoea—Cisplatin—urinary bladder cancer	5.78e-05	0.00179	CcSEcCtD
Leucovorin—Skin disorder—Etoposide—urinary bladder cancer	5.77e-05	0.00178	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	5.76e-05	0.00304	CbGpPWpGaD
Leucovorin—Feeling abnormal—Gemcitabine—urinary bladder cancer	5.74e-05	0.00177	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	5.73e-05	0.00177	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—urinary bladder cancer	5.71e-05	0.00301	CbGpPWpGaD
Leucovorin—Anorexia—Etoposide—urinary bladder cancer	5.67e-05	0.00175	CcSEcCtD
Leucovorin—Diarrhoea—Thiotepa—urinary bladder cancer	5.66e-05	0.00175	CcSEcCtD
Leucovorin—Decreased appetite—Cisplatin—urinary bladder cancer	5.64e-05	0.00174	CcSEcCtD
Leucovorin—Feeling abnormal—Fluorouracil—urinary bladder cancer	5.64e-05	0.00174	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—GSTP1—urinary bladder cancer	5.63e-05	0.00297	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	5.6e-05	0.00173	CcSEcCtD
Leucovorin—Body temperature increased—Gemcitabine—urinary bladder cancer	5.5e-05	0.0017	CcSEcCtD
Leucovorin—Dizziness—Thiotepa—urinary bladder cancer	5.47e-05	0.00169	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—urinary bladder cancer	5.44e-05	0.00168	CcSEcCtD
Leucovorin—Urticaria—Fluorouracil—urinary bladder cancer	5.44e-05	0.00168	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—RB1—urinary bladder cancer	5.42e-05	0.00286	CbGpPWpGaD
Leucovorin—Body temperature increased—Fluorouracil—urinary bladder cancer	5.41e-05	0.00167	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—urinary bladder cancer	5.36e-05	0.00283	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—CDKN1A—urinary bladder cancer	5.36e-05	0.00283	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—NQO1—urinary bladder cancer	5.35e-05	0.00282	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—IGF1—urinary bladder cancer	5.35e-05	0.00282	CbGpPWpGaD
Leucovorin—Feeling abnormal—Cisplatin—urinary bladder cancer	5.35e-05	0.00165	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	5.3e-05	0.0028	CbGpPWpGaD
Leucovorin—Dyspnoea—Etoposide—urinary bladder cancer	5.3e-05	0.00164	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—GSTP1—urinary bladder cancer	5.29e-05	0.00279	CbGpPWpGaD
Leucovorin—Vomiting—Thiotepa—urinary bladder cancer	5.26e-05	0.00162	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	5.25e-05	0.00277	CbGpPWpGaD
Leucovorin—Rash—Thiotepa—urinary bladder cancer	5.22e-05	0.00161	CcSEcCtD
Leucovorin—Dermatitis—Thiotepa—urinary bladder cancer	5.21e-05	0.00161	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.19e-05	0.00274	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	5.18e-05	0.00273	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	5.18e-05	0.00273	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—GSTM1—urinary bladder cancer	5.17e-05	0.00273	CbGpPWpGaD
Leucovorin—Decreased appetite—Etoposide—urinary bladder cancer	5.17e-05	0.0016	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.13e-05	0.00158	CcSEcCtD
Leucovorin—Body temperature increased—Cisplatin—urinary bladder cancer	5.13e-05	0.00158	CcSEcCtD
Leucovorin—Fatigue—Etoposide—urinary bladder cancer	5.12e-05	0.00158	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	5.12e-05	0.00158	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—EP300—urinary bladder cancer	5.1e-05	0.00269	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	5.1e-05	0.00269	CbGpPWpGaD
Leucovorin—Stomatitis—Epirubicin—urinary bladder cancer	5.09e-05	0.00157	CcSEcCtD
Leucovorin—Constipation—Etoposide—urinary bladder cancer	5.08e-05	0.00157	CcSEcCtD
Leucovorin—Hypersensitivity—Fluorouracil—urinary bladder cancer	5.04e-05	0.00156	CcSEcCtD
Leucovorin—Asthenia—Gemcitabine—urinary bladder cancer	4.99e-05	0.00154	CcSEcCtD
Leucovorin—Pruritus—Gemcitabine—urinary bladder cancer	4.92e-05	0.00152	CcSEcCtD
Leucovorin—Nausea—Thiotepa—urinary bladder cancer	4.91e-05	0.00152	CcSEcCtD
Leucovorin—Feeling abnormal—Etoposide—urinary bladder cancer	4.9e-05	0.00151	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—GSTM1—urinary bladder cancer	4.87e-05	0.00257	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Etoposide—urinary bladder cancer	4.86e-05	0.0015	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	4.86e-05	0.00256	CbGpPWpGaD
Leucovorin—Pruritus—Fluorouracil—urinary bladder cancer	4.84e-05	0.00149	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—NCOR1—urinary bladder cancer	4.84e-05	0.00255	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	4.82e-05	0.00254	CbGpPWpGaD
Leucovorin—Hypersensitivity—Cisplatin—urinary bladder cancer	4.78e-05	0.00148	CcSEcCtD
Leucovorin—Diarrhoea—Gemcitabine—urinary bladder cancer	4.76e-05	0.00147	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	4.74e-05	0.00146	CcSEcCtD
Leucovorin—Urticaria—Etoposide—urinary bladder cancer	4.72e-05	0.00146	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—urinary bladder cancer	4.71e-05	0.00145	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—urinary bladder cancer	4.7e-05	0.00145	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—urinary bladder cancer	4.7e-05	0.00145	CcSEcCtD
Leucovorin—Diarrhoea—Fluorouracil—urinary bladder cancer	4.68e-05	0.00145	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	4.66e-05	0.00246	CbGpPWpGaD
Leucovorin—Asthenia—Cisplatin—urinary bladder cancer	4.65e-05	0.00144	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—STAG2—urinary bladder cancer	4.63e-05	0.00244	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—LIG1—urinary bladder cancer	4.63e-05	0.00244	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	4.57e-05	0.00241	CbGpPWpGaD
Leucovorin—Dizziness—Fluorouracil—urinary bladder cancer	4.53e-05	0.0014	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.52e-05	0.00238	CbGpPWpGaD
Leucovorin—Chills—Methotrexate—urinary bladder cancer	4.5e-05	0.00139	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—GSTP1—urinary bladder cancer	4.46e-05	0.00236	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—MYC—urinary bladder cancer	4.45e-05	0.00235	CbGpPWpGaD
Leucovorin—Diarrhoea—Cisplatin—urinary bladder cancer	4.44e-05	0.00137	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—urinary bladder cancer	4.43e-05	0.00137	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.43e-05	0.00234	CbGpPWpGaD
Leucovorin—Vomiting—Gemcitabine—urinary bladder cancer	4.43e-05	0.00137	CcSEcCtD
Leucovorin—Rash—Gemcitabine—urinary bladder cancer	4.39e-05	0.00135	CcSEcCtD
Leucovorin—Dermatitis—Gemcitabine—urinary bladder cancer	4.38e-05	0.00135	CcSEcCtD
Leucovorin—Hypersensitivity—Etoposide—urinary bladder cancer	4.38e-05	0.00135	CcSEcCtD
Leucovorin—Erythema—Methotrexate—urinary bladder cancer	4.36e-05	0.00135	CcSEcCtD
Leucovorin—Vomiting—Fluorouracil—urinary bladder cancer	4.35e-05	0.00134	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—FAS—urinary bladder cancer	4.34e-05	0.00229	CbGpPWpGaD
Leucovorin—Rash—Fluorouracil—urinary bladder cancer	4.32e-05	0.00133	CcSEcCtD
Leucovorin—Dermatitis—Fluorouracil—urinary bladder cancer	4.31e-05	0.00133	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—urinary bladder cancer	4.27e-05	0.00132	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	4.27e-05	0.00225	CbGpPWpGaD
Leucovorin—Asthenia—Etoposide—urinary bladder cancer	4.26e-05	0.00132	CcSEcCtD
Leucovorin—Chills—Epirubicin—urinary bladder cancer	4.21e-05	0.0013	CcSEcCtD
Leucovorin—Pruritus—Etoposide—urinary bladder cancer	4.21e-05	0.0013	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.16e-05	0.0022	CbGpPWpGaD
Leucovorin—Alopecia—Epirubicin—urinary bladder cancer	4.14e-05	0.00128	CcSEcCtD
Leucovorin—Nausea—Gemcitabine—urinary bladder cancer	4.13e-05	0.00128	CcSEcCtD
Leucovorin—Vomiting—Cisplatin—urinary bladder cancer	4.13e-05	0.00127	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—GSTM1—urinary bladder cancer	4.1e-05	0.00216	CbGpPWpGaD
Leucovorin—Rash—Cisplatin—urinary bladder cancer	4.09e-05	0.00126	CcSEcCtD
Leucovorin—Dermatitis—Cisplatin—urinary bladder cancer	4.09e-05	0.00126	CcSEcCtD
Leucovorin—Erythema—Epirubicin—urinary bladder cancer	4.08e-05	0.00126	CcSEcCtD
Leucovorin—Diarrhoea—Etoposide—urinary bladder cancer	4.07e-05	0.00126	CcSEcCtD
Leucovorin—Nausea—Fluorouracil—urinary bladder cancer	4.07e-05	0.00126	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.05e-05	0.00125	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	4.01e-05	0.00212	CbGpPWpGaD
Leucovorin—Dysgeusia—Epirubicin—urinary bladder cancer	4e-05	0.00123	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.99e-05	0.00211	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.98e-05	0.0021	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.96e-05	0.00209	CbGpPWpGaD
Leucovorin—Malaise—Methotrexate—urinary bladder cancer	3.93e-05	0.00121	CcSEcCtD
Leucovorin—Dizziness—Etoposide—urinary bladder cancer	3.93e-05	0.00121	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—urinary bladder cancer	3.9e-05	0.00121	CcSEcCtD
Leucovorin—Chills—Doxorubicin—urinary bladder cancer	3.89e-05	0.0012	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CDKN1A—urinary bladder cancer	3.89e-05	0.00205	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	3.87e-05	0.00204	CbGpPWpGaD
Leucovorin—Nausea—Cisplatin—urinary bladder cancer	3.85e-05	0.00119	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—urinary bladder cancer	3.83e-05	0.00118	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—CDK4—urinary bladder cancer	3.82e-05	0.00201	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RRM2—urinary bladder cancer	3.82e-05	0.00201	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.79e-05	0.00117	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—urinary bladder cancer	3.78e-05	0.00117	CcSEcCtD
Leucovorin—Vomiting—Etoposide—urinary bladder cancer	3.78e-05	0.00117	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—urinary bladder cancer	3.78e-05	0.00117	CcSEcCtD
Leucovorin—Rash—Etoposide—urinary bladder cancer	3.75e-05	0.00116	CcSEcCtD
Leucovorin—Dermatitis—Etoposide—urinary bladder cancer	3.74e-05	0.00116	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—urinary bladder cancer	3.7e-05	0.00114	CcSEcCtD
Leucovorin—Malaise—Epirubicin—urinary bladder cancer	3.68e-05	0.00114	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—urinary bladder cancer	3.67e-05	0.00113	CcSEcCtD
Leucovorin—Syncope—Epirubicin—urinary bladder cancer	3.66e-05	0.00113	CcSEcCtD
Leucovorin—TYMS—Metabolism—GSTZ1—urinary bladder cancer	3.66e-05	0.00193	CbGpPWpGaD
Leucovorin—Leukopenia—Epirubicin—urinary bladder cancer	3.65e-05	0.00113	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	3.63e-05	0.00191	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.61e-05	0.0019	CbGpPWpGaD
Leucovorin—Confusional state—Methotrexate—urinary bladder cancer	3.59e-05	0.00111	CcSEcCtD
Leucovorin—Loss of consciousness—Epirubicin—urinary bladder cancer	3.59e-05	0.00111	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.56e-05	0.0011	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—urinary bladder cancer	3.54e-05	0.00109	CcSEcCtD
Leucovorin—Infection—Methotrexate—urinary bladder cancer	3.54e-05	0.00109	CcSEcCtD
Leucovorin—Nausea—Etoposide—urinary bladder cancer	3.53e-05	0.00109	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	3.51e-05	0.00185	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.5e-05	0.00108	CcSEcCtD
Leucovorin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.49e-05	0.00108	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.47e-05	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PPARG—urinary bladder cancer	3.47e-05	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTO2—urinary bladder cancer	3.47e-05	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NAT1—urinary bladder cancer	3.47e-05	0.00183	CbGpPWpGaD
Leucovorin—Skin disorder—Methotrexate—urinary bladder cancer	3.46e-05	0.00107	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—urinary bladder cancer	3.43e-05	0.00106	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.43e-05	0.00181	CbGpPWpGaD
Leucovorin—Malaise—Doxorubicin—urinary bladder cancer	3.41e-05	0.00105	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.39e-05	0.00179	CbGpPWpGaD
Leucovorin—Anorexia—Methotrexate—urinary bladder cancer	3.39e-05	0.00105	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	3.39e-05	0.00179	CbGpPWpGaD
Leucovorin—Syncope—Doxorubicin—urinary bladder cancer	3.39e-05	0.00105	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—urinary bladder cancer	3.38e-05	0.00104	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—urinary bladder cancer	3.36e-05	0.00104	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.33e-05	0.00103	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.32e-05	0.00102	CcSEcCtD
Leucovorin—Infection—Epirubicin—urinary bladder cancer	3.31e-05	0.00102	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	3.28e-05	0.00173	CbGpPWpGaD
Leucovorin—Shock—Epirubicin—urinary bladder cancer	3.28e-05	0.00101	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—urinary bladder cancer	3.27e-05	0.00101	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.26e-05	0.00101	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—SMC1A—urinary bladder cancer	3.24e-05	0.00171	CbGpPWpGaD
Leucovorin—Skin disorder—Epirubicin—urinary bladder cancer	3.24e-05	0.000999	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—MYC—urinary bladder cancer	3.23e-05	0.0017	CbGpPWpGaD
Leucovorin—Discomfort—Doxorubicin—urinary bladder cancer	3.18e-05	0.000981	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—urinary bladder cancer	3.18e-05	0.00098	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	3.17e-05	0.00167	CbGpPWpGaD
Leucovorin—Dyspnoea—Methotrexate—urinary bladder cancer	3.17e-05	0.00098	CcSEcCtD
Leucovorin—TYMS—Metabolism—UGT2B7—urinary bladder cancer	3.17e-05	0.00167	CbGpPWpGaD
Leucovorin—Dyspepsia—Methotrexate—urinary bladder cancer	3.13e-05	0.000968	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—urinary bladder cancer	3.11e-05	0.00096	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—urinary bladder cancer	3.09e-05	0.000955	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.08e-05	0.000952	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.07e-05	0.000949	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—urinary bladder cancer	3.07e-05	0.000948	CcSEcCtD
Leucovorin—Infection—Doxorubicin—urinary bladder cancer	3.06e-05	0.000946	CcSEcCtD
Leucovorin—Shock—Doxorubicin—urinary bladder cancer	3.03e-05	0.000936	CcSEcCtD
Leucovorin—ABCC3—Metabolism—GSTZ1—urinary bladder cancer	3.03e-05	0.0016	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.02e-05	0.000932	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—urinary bladder cancer	2.99e-05	0.000924	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—urinary bladder cancer	2.97e-05	0.000917	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—urinary bladder cancer	2.94e-05	0.000907	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—urinary bladder cancer	2.93e-05	0.000906	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—urinary bladder cancer	2.93e-05	0.000905	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.91e-05	0.000899	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.91e-05	0.00153	CbGpPWpGaD
Leucovorin—Decreased appetite—Epirubicin—urinary bladder cancer	2.9e-05	0.000894	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.88e-05	0.000888	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—urinary bladder cancer	2.87e-05	0.000887	CcSEcCtD
Leucovorin—ABCC3—Metabolism—GSTO2—urinary bladder cancer	2.87e-05	0.00151	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NAT1—urinary bladder cancer	2.87e-05	0.00151	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.86e-05	0.00151	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP4B1—urinary bladder cancer	2.85e-05	0.00151	CbGpPWpGaD
Leucovorin—Constipation—Epirubicin—urinary bladder cancer	2.85e-05	0.00088	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.84e-05	0.0015	CbGpPWpGaD
Leucovorin—Urticaria—Methotrexate—urinary bladder cancer	2.83e-05	0.000873	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.82e-05	0.00149	CbGpPWpGaD
Leucovorin—Body temperature increased—Methotrexate—urinary bladder cancer	2.81e-05	0.000869	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—urinary bladder cancer	2.81e-05	0.000869	CcSEcCtD
Leucovorin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.75e-05	0.000849	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—urinary bladder cancer	2.75e-05	0.000848	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.72e-05	0.000841	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	2.72e-05	0.00143	CbGpPWpGaD
Leucovorin—Dyspepsia—Doxorubicin—urinary bladder cancer	2.71e-05	0.000838	CcSEcCtD
Leucovorin—TYMS—Metabolism—SLC19A1—urinary bladder cancer	2.7e-05	0.00142	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.68e-05	0.000827	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.66e-05	0.000822	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—urinary bladder cancer	2.66e-05	0.000821	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—urinary bladder cancer	2.65e-05	0.000817	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—urinary bladder cancer	2.64e-05	0.000814	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—urinary bladder cancer	2.63e-05	0.000813	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—urinary bladder cancer	2.63e-05	0.000813	CcSEcCtD
Leucovorin—TYMS—Metabolism—PRSS3—urinary bladder cancer	2.63e-05	0.00139	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—UGT2B7—urinary bladder cancer	2.62e-05	0.00138	CbGpPWpGaD
Leucovorin—Hypersensitivity—Methotrexate—urinary bladder cancer	2.62e-05	0.00081	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.57e-05	0.00136	CbGpPWpGaD
Leucovorin—Asthenia—Methotrexate—urinary bladder cancer	2.55e-05	0.000789	CcSEcCtD
Leucovorin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.54e-05	0.000784	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.52e-05	0.000778	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—urinary bladder cancer	2.52e-05	0.000778	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	2.51e-05	0.00133	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.48e-05	0.00131	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.48e-05	0.00131	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.45e-05	0.000758	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—urinary bladder cancer	2.45e-05	0.000756	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.44e-05	0.00129	CbGpPWpGaD
Leucovorin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.44e-05	0.000752	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—urinary bladder cancer	2.44e-05	0.000752	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—urinary bladder cancer	2.44e-05	0.000752	CcSEcCtD
Leucovorin—Asthenia—Epirubicin—urinary bladder cancer	2.39e-05	0.000738	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—urinary bladder cancer	2.38e-05	0.00126	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.37e-05	0.00125	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.36e-05	0.00125	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP4B1—urinary bladder cancer	2.36e-05	0.00125	CbGpPWpGaD
Leucovorin—Pruritus—Epirubicin—urinary bladder cancer	2.36e-05	0.000728	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—urinary bladder cancer	2.35e-05	0.000727	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.3e-05	0.00121	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.29e-05	0.00121	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—urinary bladder cancer	2.28e-05	0.000704	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.27e-05	0.000701	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—EP300—urinary bladder cancer	2.27e-05	0.0012	CbGpPWpGaD
Leucovorin—Vomiting—Methotrexate—urinary bladder cancer	2.26e-05	0.000699	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CCNE1—urinary bladder cancer	2.25e-05	0.00119	CbGpPWpGaD
Leucovorin—Rash—Methotrexate—urinary bladder cancer	2.24e-05	0.000693	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—urinary bladder cancer	2.24e-05	0.000692	CcSEcCtD
Leucovorin—ABCC3—Metabolism—SLC19A1—urinary bladder cancer	2.23e-05	0.00118	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—urinary bladder cancer	2.21e-05	0.000683	CcSEcCtD
Leucovorin—Dizziness—Epirubicin—urinary bladder cancer	2.2e-05	0.00068	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—urinary bladder cancer	2.18e-05	0.000673	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.17e-05	0.00115	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PRSS3—urinary bladder cancer	2.17e-05	0.00115	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—urinary bladder cancer	2.12e-05	0.000654	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	2.12e-05	0.00112	CbGpPWpGaD
Leucovorin—Nausea—Methotrexate—urinary bladder cancer	2.11e-05	0.000653	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—urinary bladder cancer	2.11e-05	0.000651	CcSEcCtD
Leucovorin—Rash—Epirubicin—urinary bladder cancer	2.1e-05	0.000649	CcSEcCtD
Leucovorin—TYMS—Metabolism—TYMP—urinary bladder cancer	2.1e-05	0.00111	CbGpPWpGaD
Leucovorin—Dermatitis—Epirubicin—urinary bladder cancer	2.1e-05	0.000648	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	2.08e-05	0.0011	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.06e-05	0.00109	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—urinary bladder cancer	2.04e-05	0.000629	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.02e-05	0.00106	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—urinary bladder cancer	1.98e-05	0.000611	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—urinary bladder cancer	1.96e-05	0.000605	CcSEcCtD
Leucovorin—Rash—Doxorubicin—urinary bladder cancer	1.94e-05	0.0006	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—urinary bladder cancer	1.94e-05	0.0006	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.93e-05	0.00102	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	1.93e-05	0.00102	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—urinary bladder cancer	1.92e-05	0.00101	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.92e-05	0.00101	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.9e-05	0.001	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NAT2—urinary bladder cancer	1.9e-05	0.001	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—urinary bladder cancer	1.83e-05	0.000565	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	1.82e-05	0.000963	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.74e-05	0.00092	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMP—urinary bladder cancer	1.74e-05	0.000917	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—ATM—urinary bladder cancer	1.73e-05	0.000912	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDK4—urinary bladder cancer	1.72e-05	0.000908	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.69e-05	0.000893	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—RB1—urinary bladder cancer	1.67e-05	0.000883	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.67e-05	0.000881	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RRM2—urinary bladder cancer	1.64e-05	0.000865	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—urinary bladder cancer	1.62e-05	0.000857	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.59e-05	0.00084	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NAT2—urinary bladder cancer	1.57e-05	0.000829	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.000801	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.000801	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PLAU—urinary bladder cancer	1.5e-05	0.000793	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—RB1—urinary bladder cancer	1.5e-05	0.00079	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTT1—urinary bladder cancer	1.47e-05	0.000777	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	1.47e-05	0.000777	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.000716	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—urinary bladder cancer	1.32e-05	0.000694	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000663	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000663	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.25e-05	0.000659	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	1.24e-05	0.000656	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	1.24e-05	0.000654	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IGF1—urinary bladder cancer	1.22e-05	0.000646	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NQO1—urinary bladder cancer	1.22e-05	0.000646	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000643	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	1.2e-05	0.000635	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.2e-05	0.000633	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—EP300—urinary bladder cancer	1.14e-05	0.000604	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.14e-05	0.000602	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RHOA—urinary bladder cancer	1.12e-05	0.000591	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—urinary bladder cancer	1.11e-05	0.000587	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1A—urinary bladder cancer	1.08e-05	0.000567	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.07e-05	0.000566	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—EP300—urinary bladder cancer	1.02e-05	0.00054	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	0.000538	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NQO1—urinary bladder cancer	1.01e-05	0.000534	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—urinary bladder cancer	9.97e-06	0.000526	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.83e-06	0.000518	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—urinary bladder cancer	9.41e-06	0.000496	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NCOR1—urinary bladder cancer	9.38e-06	0.000495	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTM1—urinary bladder cancer	9.38e-06	0.000495	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.05e-06	0.000477	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GPX1—urinary bladder cancer	8.98e-06	0.000474	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—urinary bladder cancer	8.92e-06	0.000471	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ERCC2—urinary bladder cancer	8.82e-06	0.000465	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.57e-06	0.000452	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTP1—urinary bladder cancer	8.45e-06	0.000446	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EP300—urinary bladder cancer	8.44e-06	0.000445	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MTHFR—urinary bladder cancer	8.29e-06	0.000437	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SRC—urinary bladder cancer	8.21e-06	0.000433	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.17e-06	0.000431	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMS—urinary bladder cancer	7.85e-06	0.000414	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NCOR1—urinary bladder cancer	7.76e-06	0.00041	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTM1—urinary bladder cancer	7.76e-06	0.00041	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GPX1—urinary bladder cancer	7.43e-06	0.000392	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—urinary bladder cancer	7.32e-06	0.000386	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ERCC2—urinary bladder cancer	7.3e-06	0.000385	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTHFR—urinary bladder cancer	6.86e-06	0.000362	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—urinary bladder cancer	6.8e-06	0.000359	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPARG—urinary bladder cancer	6.72e-06	0.000355	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CREBBP—urinary bladder cancer	6.46e-06	0.000341	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—urinary bladder cancer	6.04e-06	0.000319	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—urinary bladder cancer	5.78e-06	0.000305	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPARG—urinary bladder cancer	5.56e-06	0.000293	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CREBBP—urinary bladder cancer	5.34e-06	0.000282	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—urinary bladder cancer	5.29e-06	0.000279	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—urinary bladder cancer	4.61e-06	0.000243	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—EP300—urinary bladder cancer	4.4e-06	0.000232	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—urinary bladder cancer	4.38e-06	0.000231	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—urinary bladder cancer	3.82e-06	0.000201	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—EP300—urinary bladder cancer	3.64e-06	0.000192	CbGpPWpGaD
